
AstraZeneca Pharma, Mankind Pharma partner to accelerate access to asthma medicine
Mumbai, Mar 11 (UNI) AstraZeneca Pharma India Limited and Mankind Pharma entered into an agreement for exclusive distribution of AstraZeneca’s budesonide and formoterol fumarate dihydrate (inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) combination) brand Symbicort in India. “India is contributing 13 per cent to the global asthma burden and a disproportionate 43 per cent of…